Lymphoma Large B-cell Diffuse
📧 Sign up to get email alerts when something new happens for Lymphoma Large B-cell Diffuse.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-04-04Clinical Trial Update: A Safety and Efficacy Trial of JCAR017 Combinations in Subjects With Relapsed/Refractory B-cell Malignancies [Phase 1, Phase 2]
A safety and efficacy trial update for JCAR017 combinations in relapsed/refractory B-cell malignancies across Phase 1 and Phase 2, completed…
-
CLINICAL_TRIALS trial_result · 2023-06-07Clinical Trial Update: A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial update for ASN002 in relapsed/refractory lymphoma and advanced solid tumors; the study status is TERMINATED with re…
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: CD19+Targeted CAR-T Cell Therapy for Relapsed/Refractory CD19+ B Cell Leukemia and Lymphoma [Phase 1, Phase 2]
Phase 1/2 clinical trial update for a CD19-targeted CAR-T cell therapy in relapsed/refractory CD19+ B-cell leukemias and lymphomas.
-
CLINICAL_TRIALS trial_result · 2023-02-23Clinical Trial Update: Cardioprotective Effects of Nebivolol Versus Placebo in Patients Undergoing Chemotherapy With Anthracyclines [Phase 3]
Phase 3 trial evaluating nebivolol for cardioprotective effects during anthracycline chemotherapy in cancer patients.
-
CLINICAL_TRIALS trial_result · 2022-05-25Clinical Trial Update: T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas [Phase 1]
Phase 1 clinical trial evaluating T cells expressing a fully-human anti-CD30 CAR for CD30-expressing lymphomas; study completed with posted …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-04-28Clinical Trial Update: Relevance of a Web-mediated Follow up in Patients Having a Lymphoma With a High Risk of Relapse in Complete or Partial Response [NA]
Clinical trial update for a web-mediated follow-up in lymphoma patients at high risk of relapse; the study has terminated with posted result…
-
CLINICAL_TRIALS trial_result · 2020-04-13Clinical Trial Update: Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL) [Phase 1]
Phase 1 study of ADCT-402 in relapsed or refractory B-cell lineage non-Hodgkin lymphoma completed; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-03-17Clinical Trial Update: A Study Of PF-05082566 As A Single Agent And In Combination With Rituximab [Phase 1]
Phase 1 study of PF-05082566 as a single agent and with rituximab in various lymphomas; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-03-11Clinical Trial Update: A Clinical Trial of Metformin in the Maintenance of Non-Hodgkin's Lymphoma Patients [Phase 2]
A Phase 2 clinical trial evaluating metformin for maintenance therapy in non-Hodgkin lymphoma patients is listed, with unclear status.
-
CLINICAL_TRIALS trial_result · 2019-03-12Clinical Trial Update: Cellular Immunotherapy for Viral Induced Cancer - EBV Positive Lymphomas [Phase 2]
Phase 2 trial update of cellular immunotherapy targeting EBV in viral-induced cancers including various lymphomas; the study is terminated w…
-
CLINICAL_TRIALS trial_result · 2015-09-07Clinical Trial Update: Bone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (BMT CTN 0603) [Phase 2]
Phase 2 clinical trial update on bone marrow transplantation from partially matched donors with nonmyeloablative conditioning for various bl…
-
CLINICAL_TRIALS trial_result · 2015-08-28Clinical Trial Update: Evaluating the Safety and Effectiveness of an Umbilical Cord Blood Stem Cell Transplant (BMT CTN 0604) [Phase 2]
Phase 2 clinical trial evaluating safety and effectiveness of an umbilical cord blood stem cell transplant for various hematologic malignanc…